MEET MANOUSH #2: the Tipping Point

  • 15 juni, 2020
  • 12:20

In its last Quarter ISAB reported a 722% increase in revenues compared to the same time last year. How will it keep up the momentum? CEO Manoush Masarrat…

MEET MANOUSH #1: Coronavirus

  • 5 juni, 2020
  • 13:54

Will Coronavirus have any long-term impact on ISAB? Is ISAB currently carrying out any Contract Research on Coronavirus? Will there be a ’new normal’ in the inhalation research…

ISABs nya VD Manoush Masarrat: Mina 100 första dagar

  • 4 december, 2019
  • 09:48

Den 16:e september tillträdde Manoush Masarrat som ny VD på Inhalation Sciences Sweden AB. Med 15 års erfarenhet av ledande positioner inom MedTech och 10 månader som ISAB-styrelseledamot,…

First 100 DAYS: ISAB’s New CEO Manoush Masarrat

  • 3 december, 2019
  • 13:43

On 16th September Manoush Masarrat stepped up as new CEO of Inhalation Sciences. With 15 years’ Medtech leadership experience and 10 months as an ISAB Board member, how…

New nebulizer feature drives sales – and results

  • 21 november, 2019
  • 13:38

ISAB’s new nebulizer feature delivers the stability, precision and control of a dry powder aerosol—from a liquid solution. Developed by popular demand, four nebulizer modules have already been…

Please also visit our lab-blog to read more about the latest technical updates from our lab!

Read more

See our Events schedule. Meet an ISAB expert, and explore PreciseInhale for yourself.

Upcoming events